213 related articles for article (PubMed ID: 27864793)
1. Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.
Baran A; Świderska M; Bacharewicz-Szczerbicka J; Myśliwiec H; Flisiak I
Lipids; 2017 Jan; 52(1):51-60. PubMed ID: 27864793
[TBL] [Abstract][Full Text] [Related]
2. Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin.
Baran A; Kiluk P; Świderska M; Maciaszek M; Myśliwiec H; Flisiak I
Lipids; 2019 Aug; 54(8):445-452. PubMed ID: 31281982
[TBL] [Abstract][Full Text] [Related]
3. The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.
Baran A; Swiderska M; Flisiak I
J Dermatolog Treat; 2016; 27(2):114-9. PubMed ID: 26293108
[TBL] [Abstract][Full Text] [Related]
4. Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis.
Baran A; Kiluk P; Maciaszek M; Świderska M; Flisiak I
Arch Dermatol Res; 2019 Jul; 311(5):389-397. PubMed ID: 30993401
[TBL] [Abstract][Full Text] [Related]
5. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.
Baran A; Świderska M; Myśliwiec H; Flisiak I
J Dermatolog Treat; 2017 Mar; 28(2):136-140. PubMed ID: 27165470
[TBL] [Abstract][Full Text] [Related]
6. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
[TBL] [Abstract][Full Text] [Related]
7. Serum irisin levels in patients with psoriasis.
Baran A; Myśliwiec H; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2017 Jun; 28(4):304-308. PubMed ID: 27786588
[TBL] [Abstract][Full Text] [Related]
8. Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).
Myśliwiec H; Myśliwiec P; Baran A; Flisiak I
Adv Med Sci; 2016 Sep; 61(2):207-211. PubMed ID: 26895458
[TBL] [Abstract][Full Text] [Related]
9. Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis.
Kozłowska D; Myśliwiec H; Harasim-Symbor E; Milewska AJ; Chabowski A; Flisiak I
Mol Biol Rep; 2021 May; 48(5):4421-4429. PubMed ID: 34131888
[TBL] [Abstract][Full Text] [Related]
10. Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy.
Flisiak I; Porebski P; Flisiak R; Chodynicka B
Biomarkers; 2003; 8(5):437-43. PubMed ID: 14602527
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
12. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women.
Terra X; Quintero Y; Auguet T; Porras JA; Hernández M; Sabench F; Aguilar C; Luna AM; Del Castillo D; Richart C
Eur J Endocrinol; 2011 Apr; 164(4):539-47. PubMed ID: 21257725
[TBL] [Abstract][Full Text] [Related]
13. Topical anthralin for psoriasis vulgaris: evaluation of 70 Japanese patients.
Yamamoto T; Matsuuchi M; Irimajiri J; Otoyama K; Nishioka K
J Dermatol; 2000 Jul; 27(7):482-5. PubMed ID: 10935350
[TBL] [Abstract][Full Text] [Related]
14. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.
Guaita-Esteruelas S; Saavedra-García P; Bosquet A; Borràs J; Girona J; Amiliano K; Rodríguez-Balada M; Heras M; Masana L; Gumà J
Oncologist; 2017 Nov; 22(11):1309-1315. PubMed ID: 28701570
[TBL] [Abstract][Full Text] [Related]
15. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
Ataseven A; Kesli R
G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
17. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
Suh JB; Kim SM; Cho GJ; Choi KM
Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
[TBL] [Abstract][Full Text] [Related]
18. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
[TBL] [Abstract][Full Text] [Related]
19. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.
Park SE; Rhee EJ; Lee WY; Kim WJ; Yoo SH; Bae JC; Choi ES; Park CY; Oh KW; Park SW; Kim SW
Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):525-32. PubMed ID: 21186114
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment.
Chodorowska G
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):147-51. PubMed ID: 9553912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
